Related references
Note: Only part of the references are listed.Intravenous arketamine for treatment-resistant depression: open-label pilot study
Gustavo C. Leal et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression
Elia E. Acevedo-Diaz et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava et al.
MOLECULAR PSYCHIATRY (2020)
Development of the Ketamine Side Effect Tool (KSET)
Brooke Short et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
A Word to the Wise About Intranasal Esketamine
Alan F. Schatzberg
AMERICAN JOURNAL OF PSYCHIATRY (2019)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
Mark J. Niciu et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale
Gerrit I. van Schalkwyk et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan R. Williams et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Side-effects associated with ketamine use in depression: a systematic review
Brooke Short et al.
LANCET PSYCHIATRY (2018)
Low-dose ketamine for treatment resistant depression in an academic clinical practice setting
David Feifel et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Gerard Sanacora et al.
JAMA PSYCHIATRY (2017)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
Jaskaran B. Singh et al.
BIOLOGICAL PSYCHIATRY (2016)
Ketamine: 50 Years of Modulating the Mind
Linda Li et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2016)
The use of ketamine as an antidepressant: a systematic review and meta-analysis
Caoimhe M. Coyle et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2015)
Concomitant Benzodiazepine Use Attenuates Ketamine Response
Mark A. Frye et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
C. Yang et al.
TRANSLATIONAL PSYCHIATRY (2015)
Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
Le-Ben Wan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Ketamine A Familiar Drug We Trust
Jaume Canet et al.
ANESTHESIOLOGY (2012)
Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
S(+)-ketamine Effect on Experimental Pain and Cardiac Output A Population Pharmacokinetic-Pharmacodynamic Modeling Study in Healthy Volunteers
Marnix Sigtermans et al.
ANESTHESIOLOGY (2009)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Greater vulnerability to the amnestic effects of ketamine in males
Celia J. A. Morgan et al.
PSYCHOPHARMACOLOGY (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity
J Persson et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Share Paper
